Citation Impact
Citing Papers
The human disease network
2007 Standout
Prospective identification of tumorigenic breast cancer cells
2003 Standout
From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression
2003
A Human Breast Cell Model of Preinvasive to Invasive Transition
2008
Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney
2009 StandoutNobel
Circulating microRNAs as stable blood-based markers for cancer detection
2008 Standout
The MYCN Enigma: Significance of MYCN Expression in Neuroblastoma
2006
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells
2007
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification
2007
Chromosomal Localization of DNA Amplifications in Neuroblastoma Tumors Using cDNA Microarray Comparative Genomic Hybridization
2003
Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis
2001
Hallmarks of Cancer: The Next Generation
2011 Standout
cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma
2004
High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses
2005
Detailed deletion mapping of chromosome band 14q32 in human neuroblastoma defines a 1.1-Mb region of common allelic loss
2000
Triple-Negative Breast Cancer
2010 Standout
Measurement and relevance of neuroblastoma DNA copy number changes in the post-genome era
2005
Loss of heterozygosity for chromosome 14q in neuroblastoma
2001
The biologic basis for neuroblastoma heterogeneity and risk stratification
2005
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Cellular and Gene Expression Responses Involved in the Rapid Growth Inhibition of Human Cancer Cells by RNA Interference-mediated Depletion of Telomerase RNA
2005 StandoutNobel
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Clinical utility of telomerase in cancer
2002
Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis
2007
Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastoma
2005
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
2009 Standout
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
2000 Nature
c-Myc-regulated microRNAs modulate E2F1 expression
2005 StandoutNature
Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors
2002
Cancer Metastasis: Building a Framework
2006 Standout
A microRNA component of the p53 tumour suppressor network
2007 StandoutNature
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
2005 StandoutNature
Cellular Senescence in Cancer and Aging
2007 Standout
Integrative Analysis Reveals Relationships of Genetic and Epigenetic Alterations in Osteosarcoma
2012
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Neuroblastoma: biological insights into a clinical enigma
2003 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literature
2003
Notch signaling in neuroblastoma
2004
Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse
2001
Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2
2003
Soft-Tissue Sarcomas in Adults
2005 Standout
Telomere Dysfunction Increases Mutation Rate and Genomic Instability
2001 StandoutNobel
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas
1999
Telomere dysfunction and the initiation of genome instability
2003 StandoutNobel
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Genome-Wide Analysis of Neuroblastomas using High-Density Single Nucleotide Polymorphism Arrays
2007
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
2007 StandoutNature
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
Mice without telomerase: what can they teach us about human cancer?
2000
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
2001 StandoutNobel
High‐resolution detection and mapping of genomic DNA alterations in neuroblastoma
2005
Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization
1998
Telomerase-independent Regulation of ATR by Human Telomerase RNA
2006
Oncomirs — microRNAs with a role in cancer
2006 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Genome maintenance mechanisms for preventing cancer
2001 StandoutNature
The MEIS1 Oncogene Is Highly Expressed in Neuroblastoma and Amplified in Cell Line IMR32
2001
Asparaginyl Hydroxylation of the Notch Ankyrin Repeat Domain by Factor Inhibiting Hypoxia-inducible Factor
2007 StandoutNobel
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
2011 Standout
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
2002 Standout
Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling
2005
High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma
2000
Neuroblastoma
2007 Standout
MicroRNA signatures in human cancers
2006 Standout
High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping
2006
Region-specific detection of neuroblastoma loss of heterozygosity at multiple loci simultaneously using a SNP-based tag-array platform
2005
Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues
2005
The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2
2002
Variety and complexity of chromosome 17 translocations in neuroblastoma
2003
The Hallmarks of Aging
2013 Standout
Mechanism and relevance of ploidy in neuroblastoma
2000
The age of cancer
2000 Nature
Phosphorylation of H2AX at Short Telomeres in T Cells and Fibroblasts
2004 StandoutNobel
A microRNA polycistron as a potential human oncogene
2005 StandoutNature
Genetic parameters of neuroblastomas
2002
The Causes and Consequences of Polyploidy in Normal Development and Cancer
2011
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis
2003
Gains of 13q are correlated with a poor prognosis in liposarcoma
2004
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
Genome-wide screen for allelic imbalance in a mouse model for neuroblastoma.
2000
Limb Salvage and Amputation in Survivors of Pediatric Lower-Extremity Bone Tumors: What Are the Long-Term Implications?
2002
Heterogeneity in Breast Cancer and the Problem of Relevance of Findings
1999
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
PPM1D is a potential target for 17q gain in neuroblastoma.
2003
RNA–protein analysis using a conditional CRISPR nuclease
2013 StandoutNobel
Telomerase core components protect Candida telomeres from aberrant overhang accumulation
2007 StandoutNobel
Telomerase contributes to tumorigenesis by a telomere length-independent mechanism
2002
Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line.
2001
The Protein Kinase Complement of the Human Genome
2002 StandoutScience
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
Reconstructing the DNA Methylation Maps of the Neandertal and the Denisovan
2014 StandoutScienceNobel
Correlation of Early Metastatic Response by123I-Metaiodobenzylguanidine Scintigraphy With Overall Response and Event-Free Survival in Stage IV Neuroblastoma
2003
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
MYCN Expression Is Not Prognostic of Adverse Outcome in Advanced-Stage Neuroblastoma With Nonamplified MYCN
2000
Broken Limits to Life Expectancy
2002 StandoutScience
Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.
2003
Molecular Biology of Neuroblastoma
1999
Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study
2000
Identification and Characterization of a Novel Gene, C13orf25 , as a Target for 13q31-q32 Amplification in Malignant Lymphoma
2004
DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.
1998
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
2007 Standout
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
2008 Standout
SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.
2002
Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis
2004
Works of C. Brinkschmidt being referenced
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lackingMYCN amplification
2001
Evaluation of Chemotherapy Response in Primary Bone Tumors with F-18 FDG Positron Emission Tomography Compared with Histologically Assessed Tumor Necrosis
2000
Gain of Chromosome Arm 17q and Adverse Outcome in Patients with Neuroblastoma
1999
Comparative genomic hybridization of ductal carcinomain situ of the breast?evidence of multiple genetic pathways
1999
Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas
2001
Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes
1999
COMPARATIVE GENOMIC HYBRIDIZATION (CGH) ANALYSIS OF NEUROBLASTOMAS—AN IMPORTANT METHODOLOGICAL APPROACH IN PAEDIATRIC TUMOUR PATHOLOGY
1997
Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there?
2001
Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas
2002
Limb Salvage and Outcome of Osteosarcoma
1999
Comparative genomic hybridization and telomerase activity analysis identify two biologically different groups of 4s neuroblastomas
1998
Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome
2001
Telomerase activity distinguishes between neuroblastomas with poor prognosis
1999
Sublocalization of putative tumor suppressor gene loci on chromosome arm 14q in neuroblastoma
1999
Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events.
1997
Sublocalization of putative tumor suppressor gene loci on chromosome arm 14q in neuroblastoma
1999
Unequivocal Delineation of Clinicogenetic Subgroups and Development of a New Model for Improved Outcome Prediction in Neuroblastoma
2005
A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma
2000